Bixiye
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Natiijooyinka Raadinta
Soo bandhiga 3201 - 3210 ee natiijooyinka 3688
Bixiye
P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P76-17 Centurion moving to Blue Cross for Claims Administration Services
Taariikhda uu dhaqangalayo Barnaamijka: Des 07, 2017
Bixiye
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2018
Bixiye
2018 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2016